These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 25432781
1. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus. Iwata S, Yamaoka K, Niiro H, Jabbarzadeh-Tabrizi S, Wang SP, Kondo M, Yoshikawa M, Akashi K, Tanaka Y. Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781 [Abstract] [Full Text] [Related]
2. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Fleischer SJ, Giesecke C, Mei HE, Lipsky PE, Daridon C, Dörner T. Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507 [Abstract] [Full Text] [Related]
3. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells. Fleischer SJ, Daridon C, Fleischer V, Lipsky PE, Dörner T. Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408 [Abstract] [Full Text] [Related]
4. B-cell subsets, signaling and their roles in secretion of autoantibodies. Iwata S, Tanaka Y. Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261 [Abstract] [Full Text] [Related]
5. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus. Chang NH, Li TT, Kim JJ, Landolt-Marticorena C, Fortin PR, Gladman DD, Urowitz MB, Wither JE. J Autoimmun; 2015 Apr; 58():100-10. PubMed ID: 25678471 [Abstract] [Full Text] [Related]
6. Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases. Ghosh D, Tsokos GC. Autoimmunity; 2010 Feb; 43(1):48-55. PubMed ID: 20001666 [Abstract] [Full Text] [Related]
7. BTLA Expression and Function Are Impaired on SLE B Cells. Wiedemann A, Lettau M, Weißenberg SY, Stefanski AL, Schrezenmeier EV, Rincon-Arevalo H, Reiter K, Alexander T, Hiepe F, Lino AC, Dörner T. Front Immunol; 2021 Feb; 12():667991. PubMed ID: 33968071 [Abstract] [Full Text] [Related]
8. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Enyedy EJ, Nambiar MP, Liossis SN, Dennis G, Kammer GM, Tsokos GC. Arthritis Rheum; 2001 May; 44(5):1114-21. PubMed ID: 11352243 [Abstract] [Full Text] [Related]
9. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus. Taher TE, Parikh K, Flores-Borja F, Mletzko S, Isenberg DA, Peppelenbosch MP, Mageed RA. Arthritis Rheum; 2010 Aug; 62(8):2412-23. PubMed ID: 20506108 [Abstract] [Full Text] [Related]
10. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation. Iwata S, Yamaoka K, Niiro H, Nakano K, Wang SP, Akashi K, Tanaka Y. J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243 [Abstract] [Full Text] [Related]
11. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Nakou M, Papadimitraki ED, Fanouriakis A, Bertsias GK, Choulaki C, Goulidaki N, Sidiropoulos P, Boumpas DT. Clin Exp Rheumatol; 2013 Jun; 31(2):172-9. PubMed ID: 23137515 [Abstract] [Full Text] [Related]
12. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S. Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415 [Abstract] [Full Text] [Related]
13. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus. Vásquez A, Baena A, González LA, Restrepo M, Muñoz CH, Vanegas-García A, Ortiz-Reyes B, Abdoel N, Rojas M, García LF, Vásquez G. Cell Signal; 2019 Jun; 58():9-19. PubMed ID: 30840855 [Abstract] [Full Text] [Related]
14. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O. Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260 [Abstract] [Full Text] [Related]
15. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Bijl M, Horst G, Limburg PC, Kallenberg CG. Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879 [Abstract] [Full Text] [Related]
16. T cell receptor-associated protein tyrosine kinases: the dynamics of tolerance regulation by phosphorylation and its role in systemic lupus erythematosus. Barrera-Vargas A, Gómez-Martín D, Alcocer-Varela J. Hum Immunol; 2014 Sep; 75(9):945-52. PubMed ID: 25173412 [Abstract] [Full Text] [Related]
17. Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells. Chauhan AK, Moore TL. Clin Exp Immunol; 2012 Feb; 167(2):235-45. PubMed ID: 22235999 [Abstract] [Full Text] [Related]
18. Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. Krishnan S, Juang YT, Chowdhury B, Magilavy A, Fisher CU, Nguyen H, Nambiar MP, Kyttaris V, Weinstein A, Bahjat R, Pine P, Rus V, Tsokos GC. J Immunol; 2008 Dec 01; 181(11):8145-52. PubMed ID: 19018007 [Abstract] [Full Text] [Related]
19. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT. J Eur Acad Dermatol Venereol; 2009 Apr 01; 23(4):433-7. PubMed ID: 19335730 [Abstract] [Full Text] [Related]